Errin Samuëlsz
3PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Oct 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.Daniel H Ahn, Maya Ridinger, Timothy L Cannon
|Jan 17, 2024
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.Daniel H Ahn, Afsaneh Barzi, Maya Ridinger
|Oct 01, 2020
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.Amer M Zeidan, Maya Ridinger, Tara L Lin
Pageof 1
Frequent Collaborators
3 joint publications
Heinz-Josef Lenz
2 joint publications
Daniel H Ahn
2 joint publications
Afsaneh Barzi
2 joint publications
Maya Ridinger
2 joint publications
Ramanand A Subramanian
2 joint publications
Peter J P Croucher
1 joint publications
Amer M Zeidan
1 joint publications
Tara L Lin
1 joint publications
Pamela S Becker
1 joint publications
Tod Smeal
